## Abstract The relationship between the strength of the estrogenic and progestational components of combined oral contraceptives and risk of endometrial carcinoma was examined in a multinational hospitalβbased caseβcontrol study comparing 220 cases from 7 countries with 1,537 ageβ and hospitalβmat
β¦ LIBER β¦
Endometrial Hyperplasia Risk in Relation to Recent Use of Oral Contraceptives and Hormone Therapy
β Scribed by Meira Epplein; Susan D. Reed; Lynda F. Voigt; Katherine M. Newton; Victoria L. Holt; Noel S. Weiss
- Book ID
- 116225479
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 126 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1047-2797
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hormonal content of combined oral contra
β
Karin A. Rosenblatt; David B. Thomas
π
Article
π
1991
π
John Wiley and Sons
π
French
β 543 KB
Correlates of hormone replacement therap
β
Erica Frank; John Rock; Lisa Elon
π
Article
π
2001
π
Lippincott Williams and Wilkins
π
English
β 185 KB
Oral contraceptive use, hormone replacem
β
Geoffrey C. Kabat; Anthony B. Miller; Thomas E. Rohan
π
Article
π
2007
π
John Wiley and Sons
π
French
β 69 KB
π 2 views
## Abstract Evidence from epidemiologic studies suggests a possible role of exogenous and endogenous hormones in colorectal carcinogenesis in women. However, with respect to exogenous hormones, in contrast to hormone replacement therapy, few cohort studies have examined oral contraceptive use in re
Hormone therapy in postmenopausal women
β
Roberts, Helen; Hickey, Martha; Lethaby, Anne
π
Article
π
2014
π
Elsevier Science
π
English
β 195 KB
Use of oral contraceptives and hormone r
β
Vivan Lundberg; Hanna Tolonen; Birgitta Stegmayr; Kari Kuulasmaa; Kjell Asplund
π
Article
π
2004
π
Elsevier Science
π
English
β 86 KB
Previous oral contraceptive use and brea
β
Vanessa Dumeaux; Agnès Fournier; Eiliv Lund; Françoise Clavel-Chapelon
π
Article
π
2005
π
Springer Netherlands
π
English
β 187 KB